No Data
No Data
No Data
No Data
No Data
China Resources Pharmaceutical (03320): Beijing Pharmaceutical has completed a transaction to transfer 100% of China Resources Zizhu's interests to China Resources Shuanghe
China Resources Pharmaceutical (03320) issued an announcement to register share transfers with relevant counterpart departments of the State Administration of Market Supervision and Administration...
Zhitong FinanceApr 18 06:42 ET
China Resources Pharmaceuticals (03320.HK) completed the proposed internal restructuring involving China Resources Zizhu
Gelonghui, April 18, 丨 China Resources Pharmaceutical (03320.HK) announced the proposed internal restructuring of China Resources Zizhu Pharmaceutical Co., Ltd. (“China Resources Zizhu”). The board of directors is pleased to announce that the share transfer registration with the relevant counterpart department of the State Administration of Market Supervision and Administration has been completed. Therefore, as of the announcement date, according to the terms of the share transfer agreement, Beijing Pharmaceutical has completed a transaction to transfer 100% of China Resources Zizhu's interests to China Resources Shuanghe.
Gelonghui FinanceApr 18 06:42 ET
China Resources Pharma Unit Issues 3 Billion Yuan Bonds
China Resources Pharmaceutical Group (HKG:3320) said its unit CR Pharmaceutical Commercial sold 3 billion yuan of bonds in China, according to a Wednesday filing with the Hong Kong Exchange. Two varie
MT NewswiresApr 18 01:00 ET
China Resources Pharmaceuticals (03320): China Resources Pharmaceuticals commercially issues no more than 3 billion yuan of corporate bonds
Zhitong Finance App News, China Resources Pharmaceutical (03320) announced that China Resources Pharmaceutical has issued the first issue of 2024 corporate bonds in China, with an issuance scale of no more than RMB 3 billion. The coupon interest rate for corporate bond type 1 is 2.45%, and the term is three years. The coupon interest rate for corporate bond type 2 is 2.63%, and the term is five years. The funds raised from the issuance of this issue of bonds will mainly be used to repay interest-bearing debts.
Zhitong FinanceApr 17 07:39 ET
China Resources Pharmaceuticals (03320.HK) signs 2024 IT service procurement agreement with China Resources Mathematics
Gelonghui, April 12, 丨 China Resources Pharmaceutical (03320.HK) announced that on April 12, 2024, the company signed a 2024 IT service procurement framework agreement with China Resources Mathematics. According to this, the Group has agreed to purchase IT services from China Resources Mathematical Group for the period from April 12, 2024 to December 31, 2024.
Gelonghui FinanceApr 12 07:01 ET
China Resources Pharmaceutical (03320.HK): Donga Ejiao's net profit for the first quarter is expected to be about 334 million to 357 million yuan
Gelonghui, April 12, 丨 China Resources Pharmaceutical (03320.HK) issued an announcement. On April 11, 2024, Donga Ejiao (000423.SZ) announced its results forecast for the three months ending March 31, 2024. According to this, the net profit attributable to shareholders of Donga Ejiao for the three months ending March 31, 2024 is estimated to be approximately RMB 334 million to RMB 357 million (approximately RMB 2303 million for the same period last year). Net profit after deducting non-recurring profit and loss is estimated to be approximately RMB 309 million to RMB 332 million ( Approximately RMB 2 for the same period last year.
Gelonghui FinanceApr 11 18:19 ET
No Data
No Data